U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
150361150361Diagnosis Of Vertigo With New ImagingCompletedNo Results AvailableVertigoDevice: Functional MRI imaginghttps://ClinicalTrials.gov/show/NCT00593216
150362150362Brain Tissue Specimen CollectionEnrolling by invitationNo Results AvailableBrain Diseaseshttps://ClinicalTrials.gov/show/NCT00593203
150363150363Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in KeratoconusRecruitingNo Results AvailableHydrops in KeratoconusDrug: Gas SF6 (Sulfur Hexafluoride)https://ClinicalTrials.gov/show/NCT00593190
150364150364A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate PsoriasisCompletedNo Results AvailablePsoriasis VulgarisDrug: PTH (1-34) Gel / Placebo Gelhttps://ClinicalTrials.gov/show/NCT00593177
150365150365Clinical Study of the LRS ThermoSuitâ„¢ System in Post Arrest Patients With Intravenous Infusion of Magnesium SulfateNot yet recruitingNo Results AvailableDeath, Sudden, Cardiac|ComaDevice: Cooling with ThermoSuit with Magnesium Sulfate Infusion|Device: Cooling with ThermoSuit with Normal Saline Infusionhttps://ClinicalTrials.gov/show/NCT00593164
150366150366Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis CCompletedNo Results AvailableHepatitis COther: Locteron (controlled-release interferon alpha 2b)|Biological: pegylated IFNa2bhttps://ClinicalTrials.gov/show/NCT00593151
150367150367Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidateCompletedNo Results AvailableDrug Binding to DAT ReceptorsDrug: dex-methylphenidatehttps://ClinicalTrials.gov/show/NCT00593138
150368150368Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-Maintained Patients.Active, not recruitingNo Results AvailableCocaine Dependence|Opioid DependencyDrug: levetiracetamhttps://ClinicalTrials.gov/show/NCT00593125
150369150369Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS MethylphenidateCompletedHas ResultsADHDDrug: OROS methylphenidate|Other: No interventionhttps://ClinicalTrials.gov/show/NCT00593112
150370150370A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective DisorderCompletedNo Results AvailableBipolar DisorderDrug: Bupropion|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00593099
150371150371Virtual Reality in Burn Pain ManagementCompletedNo Results AvailableBurns|PainProcedure: Pain management|Other: Standard of care/no virtual reality gamehttps://ClinicalTrials.gov/show/NCT00593086
150372150372Use of Novel Tailored Reminders in Rural Primary CareCompletedNo Results AvailableColorectal CancerBehavioral: Electronic tailored messaging|Behavioral: General Reminder Messagehttps://ClinicalTrials.gov/show/NCT00593073
150373150373Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal CancerCompletedNo Results AvailableColorectal Cancer|Colorectal AdenocarcinomaDrug: Temsirolimus|Drug: Cetuximabhttps://ClinicalTrials.gov/show/NCT00593060
150374150374LDL-Cholesterol Lowering Effect of KB2115 as Add on to StatinCompletedNo Results AvailableDyslipidemiaDrug: KB2115https://ClinicalTrials.gov/show/NCT00593047
150375150375Medical Office Intervention for Adolescent Drug Use - Attention Study SupplementCompletedNo Results AvailableSubstance-related Disordershttps://ClinicalTrials.gov/show/NCT00593034
150376150376Diagnostic Evaluation of Obscure Gastrointestinal BleedingWithdrawnNo Results AvailableObscure Gastrointestinal Bleedinghttps://ClinicalTrials.gov/show/NCT00593021
150377150377Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic CancerTerminatedNo Results AvailablePancreatic AdenocarcinomaDrug: Temsirolimus|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00593008
150378150378Creatine Safety and Tolerability in Premanifest HD: PRECRESTCompletedNo Results AvailableHuntington DiseaseDrug: Creatine monohydrate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00592995
150379150379Bisphosphonate-Associated Jaw Osteonecrosis and PET ImagingCompletedNo Results AvailableBisphosphonate-associated ONJ|Osteomyelitis of the Jaw|Osteolytic Lesions of the Jaw|Osteoradionecrosis of the Jawhttps://ClinicalTrials.gov/show/NCT00592982
150380150380Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: metformin|Drug: biphasic insulin asparthttps://ClinicalTrials.gov/show/NCT00592969
150381150381PET Study Examining the Dopaminergic Activity of Armodafinil in AdultsCompletedHas ResultsHealthyDrug: armodafinilhttps://ClinicalTrials.gov/show/NCT00592943
150382150382Olanzapine in the Treatment of Anorexia NervosaCompletedNo Results AvailableAnorexia NervosaDrug: olanzapine|Drug: placebohttps://ClinicalTrials.gov/show/NCT00592930
150383150383OSTPRE-Fracture Prevention StudyCompletedNo Results AvailableFractures|OsteoporosisDietary Supplement: calcium carbonate and cholecalciferolhttps://ClinicalTrials.gov/show/NCT00592917
150384150384Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)CompletedHas ResultsNeuralgiaDrug: E2007https://ClinicalTrials.gov/show/NCT00592904
150385150385Oxygen Toxicity of HBOT in Chronic Brain InjuryRecruitingNo Results AvailableAdult and Pediatric Chronic Cerebral DisordersDrug: Hyperbaric oxygen therapyhttps://ClinicalTrials.gov/show/NCT00592891
150386150386Risk Factors for Adult-Onset Brain TumorsEnrolling by invitationNo Results AvailableBrain Neoplasm, Primary|Brain Neoplasms, Malignant|Brain Neoplasms, Benignhttps://ClinicalTrials.gov/show/NCT00592865
150387150387Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar DisorderTerminatedHas ResultsPediatric Bipolar Disorder|Pediatric OCDDrug: fluoxetinehttps://ClinicalTrials.gov/show/NCT00592852
150388150388Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal WomenCompletedHas ResultsNocturnal Vasomotor SymptomsDrug: SCE-B|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00592839
150389150389HMP (Home Macular Perimeter) -Usability TrialCompletedNo Results AvailableAge Related Macular Degenerationhttps://ClinicalTrials.gov/show/NCT00592826
150390150390Efficacy of a Post-Rehabilitation Exercise InterventionCompletedNo Results AvailableHip Fracture|DisabilityBehavioral: Enhanced Strong for Life|Behavioral: cardiovascular nutrition educationhttps://ClinicalTrials.gov/show/NCT00592813

* Görseller ve İçerik tekif hakkına sahip olabilir